AMEEK (Amikacin Sulfate 250/500 mg) is a powerful antibacterial injection effective against severe gram-negative infections. It plays a key role in managing Pseudomonas aeruginosa and other serious hospital-acquired infections. Recommended for bacteraemia, peritonitis, meningitis, septicemia, and RTI/UTI, AMEEK ensures reliable, fast infection control in critical care cases.

 

Category:

Description

AMEEK (Amikacin Sulfate 250/500 mg) is a trusted and powerful antibacterial injection designed to manage severe and life-threatening infections. It plays a vital role in treating infections caused by Pseudomonas aeruginosa, a major cause of complications, especially in patients with extensive burns. AMEEK is highly effective against serious aerobic gram-negative bacillary infections and is known for its reliable, fast-acting therapeutic action.

It can be safely combined with cephalosporins, making it suitable for broad-spectrum infection management. AMEEK is recommended in conditions such as bacteraemia, peritonitis, meningitis, septicemia, nosocomial infections, and respiratory or urinary tract infections.

With strong clinical efficacy and dependable results, AMEEK provides essential support for critical care treatment and rapid infection control.